Alzheimer's drug gets FDA panel's backing, setting the stage for broader use
U.S. health advisers are backing the full approval of an Alzheimer's drug that received preliminary approval last year
U.S. health advisers are backing the full approval of an Alzheimer's drug that received preliminary approval last year
A group of Amazon workers upset about recent layoffs, a return-to-office mandate and the company’s environmental impact...
Google has announced it’s allowing more people to interact with “Bard."
A general strike in Greece called in response to a rail disaster last month has grounded flights and extensively disrupt...